Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.

Journal of Korean medical science - 1 Apr 1999

Park Y M, Byun B H, Choi J Y, Bae S H, Kim B S, So H S, Ryu W S

Abstract excerpt

To evaluate the clinical feasibility of the antibody titer against a chimeric polypeptide (named Core 518), in which a domain of Core and NS3 of hepatitis C virus (HCV) was fused, ELISA was performed in a total of 76 serum samples. Each serum was serially diluted using two-fold dilution method with distilled water into 10 concentrations. They were all positive for second generation anti-HCV assay (HCV EIA II;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis C
Share to Hepatitis C Antibodies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C Antigens

Share to Immunoblotting

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Viral Core Proteins

Share to Viral Nonstructural Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 10331562
DOI: 10.3346/jkms.1999.14.2.165
PMCID: PMC3054362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.PMID 10331562Read ↗

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.Semantic proximity Read ↗

Determination of the human antibody response to the neutralization epitopes encompassing amino acids 313-327 and 432-443 of hepatitis C virus E1E2 glycoproteins.Semantic proximity Read ↗

Circulating viral core and E1 antigen levels as supplemental markers for HCV chronic hepatitis.Semantic proximity Read ↗

The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV.Semantic proximity Read ↗

[Evaluation of ARCHITECT HCV core antigen assay].Semantic proximity Read ↗

Immunoreactivity assessment of hepatitis C virus NS3 protease and NS5A proteins expressed in TOPO cloning system.Semantic proximity Read ↗

Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-alpha2b and ribavirin therapy in patients with genotype 1 and high viral loads.Semantic proximity Read ↗

Screening for serum biomarkers in patients with chronic hepatitis B with hepatitis B surface antigen seroclearance, following pegylated interferon alpha therapy.Semantic proximity Read ↗

Type-specific antibody for hepatitis C virus detected by use of NS-4 peptide and hepatitis C virus genome in Korea.Semantic proximity Read ↗

Design of novel conformational and genotype-specific antigens for improving sensitivity of immunoassays for hepatitis C virus-specific antibodies.Semantic proximity Read ↗

Inhibition of Hepatitis C Virus Production by Aptamers against the Core ProteinSemantic proximity Read ↗

Expression of HCV genotype-4 core antigen in prokaryotic E. coli system for diagnosis of HCV infection in Egypt.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.